Cite
APA Citation
Moonesinghe, K., & Talati, K. (2017). what is the appropriate dose for spironolactone as a fourth‐line agent in treating resistant hypertension?. Evidence-based practice, 20(6), . http://access.bl.uk/ark:/81055/vdc_100122868752.0x00001c